Key facts
- · Type: New offering first sale 2026-08-26 · Amount sold: $50K · Total offering: $50K · SEC filing
- · Type: New offering first sale 2025-11-01 · Amount sold: $200K · Total offering: $1.50M · SEC filing
- · Type: New offering first sale 2024-01-23 · Amount sold: $454K · Total offering: $2.50M · SEC filing
Is Neuro-Vascular Research & Design Corp a real, registered company?
Neuro-Vascular Research & Design Corp is a registered filer with the SEC (CIK 2004466) and has filed since 2024-01-25. 3 filings are on record, the latest on 2026-08-31.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs Neuro-Vascular Research & Design Corp?
Neuro-Vascular Research & Design Corp's filings name Henry Day, Jr., Jeffrey Owen, Nicolas Chung and 1 more as its officers, directors or promoters.
How much has Neuro-Vascular Research & Design Corp raised?
Its new offerings report $704K sold across 3 offerings, as its own filings state.
Run the free check on Neuro-Vascular Research & Design Corp →
Tucson, ARIZONA
Other Health Care
3
$704K
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-08-31 | New offering first sale 2026-08-26 | $50K | $50K | details · SEC filing |
| 2025-11-07 | New offering first sale 2025-11-01 | $200K | $1.50M | details · SEC filing |
| 2024-01-25 | New offering first sale 2024-01-23 | $454K | $2.50M | SEC filing |
Want the whole picture on Neuro-Vascular Research & Design Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Neuro-Vascular Research & Design Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neuro-Vascular Research & Design Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Neuro-Vascular Research & Design Corp's own filings with the SEC. The people those filings name are on the team page.